Statewide
Massachusetts Department of Public Health, Office of Emergency Medical Services
Massachusetts Department of Public Health, Office of Emergency Medical Services (MA) carries 49 drugs across 191 dose entries in its current published protocol, effective 2026-09-01.
Drugs and doses49
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 650–1000 mg | PO | not captured | standing | page 37 |
| Mild to moderate pain | adult | 650–1000 mg | IV | not captured | standing | page 37 |
| Mild to moderate pain | peds | 15 mg/kg | PO | not captured | standing | page 37 |
| Mild to moderate pain | peds | 15 mg/kg | IV | not captured | standing | page 37 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 6 mg | IV/IO | not captured | standing | pages 66, 67 |
| SVT | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 66, 67 |
| Wide-complex tachycardia | adult | 6 mg | IV | not captured | standing | page 68 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 2.5 mg | NEB | not captured | standing | pages 16, 17 |
| Anaphylaxis | peds | 1.25 mg | NEB | not captured | standing | pages 16, 17 |
| Asthma / bronchospasm | adult | 2.5–3 mg | NEB | not captured | standing | pages 23, 25 |
| Asthma / bronchospasm | peds | 1.25 mg | NEB | not captured | standing | pages 23, 25 |
| Other | adult | 2.5–3 mg | NEB | not captured | standing | page 38 |
| Other | peds | 2.5–3 mg | NEB | not captured | standing | page 38 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 150 mg | IV/IO | not captured | standing | pages 56, 66 |
| Cardiac arrest | adult | 300 mg | IV/IO | not captured | standing | pages 61, 62 |
| Cardiac arrest | peds | 5 mg/kg | IV/IO | not captured | standing | pages 61, 62 |
| SVT | adult | 150 mg | IV/IO | not captured | standing | page 66 |
| Wide-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | page 68 |
| Wide-complex tachycardia | peds | 5 mg/kg | IV/IO | not captured | standing | page 68 |
Amyl Nitrite
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 2 inhalants | NEB | not captured | standing | page 38 |
| Cyanide poisoning | peds | 2 inhalants | NEB | not captured | standing | page 38 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324–325 mg | PO | not captured | standing | pages 53, 162 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | pages 57, 58 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 57, 58 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 59, 60 |
| Cardiac arrest | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 59, 60 |
| Nerve agent exposure | adult | 2 mg | IV/IO | not captured | standing | page 29 |
| Other | adult | 2–5 mg | IV/IO | not captured | standing | page 38 |
| Other | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 38 |
Buprenorphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 16 mg | SL | not captured | standing | page 105 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 20 mg/kg | IV/IO | not captured | standing | pages 38, 57 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 20 mg/kg | IV/IO | not captured | standing | pages 38, 57 |
| Hyperkalemia | adult | 1 g | IV | not captured | standing | pages 49, 142 |
| Hyperkalemia | peds | 20 mg/kg | IV | not captured | standing | pages 49, 142 |
| Other | adult | 20 mg/kg | IV/IO | not captured | standing | page 32 |
| Other | adult | 20 mg/kg | IV/IO | not captured | standing | page 59 |
| Other | peds | 20 mg/kg | IV/IO | not captured | standing | page 32 |
| Other | peds | 20 mg/kg | IV/IO | not captured | standing | page 59 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 1 g | IV | not captured | standing | pages 49, 142 |
| Hyperkalemia | peds | 20 mg/kg | IV | not captured | standing | pages 49, 142 |
| Other | adult | 20 mg/kg | IV/IO | not captured | standing | page 32 |
| Other | adult | 20 mg/kg | IV/IO | not captured | standing | page 59 |
| Other | peds | 20 mg/kg | IV/IO | not captured | standing | page 32 |
| Other | peds | 20 mg/kg | IV/IO | not captured | standing | page 59 |
Cetirizine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 10 mg | PO/ODT | not captured | standing | pages 16, 17 |
| Anaphylaxis | adult | 10 mg | IV | not captured | standing | pages 16, 17 |
| Anaphylaxis | peds | 2.5 mg | PO/ODT | not captured | standing | pages 16, 17 |
| Anaphylaxis | peds | 2.5 mg | IV | not captured | standing | pages 16, 17 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 25 g | IV/IO | not captured | standing | page 142 |
| Hyperkalemia | peds | 0.5 g/kg | IV/IO | not captured | standing | page 142 |
| Hypoglycemia | adult | 12.5 g | IV/IO | not captured | standing | pages 18, 19 |
| Hypoglycemia | peds | 0.5 g/kg | IV/IO | not captured | standing | pages 18, 19 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 10 mg | IM | not captured | standing | page 29 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 0.25 mg/kg | IV/IO | not captured | standing | page 56 |
| SVT | adult | 0.25 mg/kg | IV/IO | not captured | standing | page 66 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 50 mg | IV | not captured | standing | page 158 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 2–20 mcg/kg | IV/IO | not captured | standing | page 16 |
| Bradycardia | adult | 2–20 mcg/kg | IV/IO | not captured | standing | page 57 |
| Hypotension / shock | adult | 2–20 mcg/kg | IV/IO | not captured | standing | pages 42, 44 |
| Hypotension / shock | peds | 2–20 mcg/kg | IV/IO | not captured | standing | pages 42, 44 |
| Other | adult | 2–20 mcg/kg | IV/IO | not captured | standing | page 79 |
| Sepsis | adult | 2–20 mcg/kg | IV/IO | not captured | standing | page 45 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3 mg | IM | not captured | standing | pages 16, 17 |
| Anaphylaxis | peds | 0.15 mg | IM | not captured | standing | pages 16, 17 |
| Asthma / bronchospasm | adult | 0.1–0.5 mg | IV/IO | not captured | standing | page 23 |
| Asthma / bronchospasm | adult | 0.3 mg | IM | not captured | standing | pages 23, 25 |
| Asthma / bronchospasm | peds | 0.15 mg | IM | not captured | standing | pages 23, 25 |
| Bradycardia | adult | 2–10 mcg | IV/IO | not captured | standing | pages 57, 58 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 57, 58 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 59, 60, 61, 62 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 59, 60, 61, 62 |
| Sepsis | peds | 0.1–1 mcg/kg | IV/IO | not captured | standing | pages 45, 46 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5–1 mcg/kg | IV/IO | not captured | standing | page 89 |
| Mild to moderate pain | adult | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | page 37 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | page 37 |
| Procedural sedation | adult | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | page 124 |
| Procedural sedation | adult | 50–100 mcg | IV/IO/IM/IN | not captured | standing | page 145 |
| Procedural sedation | peds | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | page 145 |
Furosemide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 20–40 mg | IV/IO | not captured | standing | page 63 |
| Hyperkalemia | adult | 0.5–1 mg/kg | IV/IO | not captured | standing | page 142 |
| Hyperkalemia | peds | 0.5–1 mg/kg | IV/IO | not captured | standing | page 142 |
| Other | adult | 40 mg | IV/IO | not captured | standing | page 38 |
| Other | peds | 0.5 mg/kg | IV/IO | not captured | standing | page 38 |
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1–5 mg | IV/IO/IM | not captured | standing | page 38 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.5 or 1 mg | IV/IO/IM | not captured | standing | page 38 |
| Hypoglycemia | adult | 1 mg | IM/IN | not captured | standing | pages 18, 19 |
| Hypoglycemia | adult | 1 mg | IV/IO/IM/IN | not captured | standing | page 19 |
| Hypoglycemia | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 19 |
| Hypoglycemia | peds | 0.5 mg | IM/IN | not captured | standing | pages 18, 19 |
Haloperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 5 mg | IM | not captured | standing | page 21 |
Hydrocortisone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 100 mg | IV/IO/IM | not captured | standing | page 15 |
| Adrenal crisis | peds | 2 mg/kg | IV/IO/IM | not captured | standing | page 15 |
| Anaphylaxis | adult | 100 mg | IV/IO/IM | not captured | standing | pages 16, 17 |
| Anaphylaxis | peds | 2 mg/kg | IV/IO/IM | not captured | standing | pages 16, 17 |
| Asthma / bronchospasm | adult | 100 mg | IV/IO/IM | not captured | standing | pages 23, 26 |
| Asthma / bronchospasm | peds | 2 mg/kg | IV/IO/IM | not captured | standing | pages 23, 26 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV/IO | not captured | standing | page 38 |
| Cyanide poisoning | adult | 5 g | IV/IO | not captured | standing | page 70 |
| Cyanide poisoning | peds | 70 mg/kg | IV/IO | not captured | standing | page 38 |
| Cyanide poisoning | peds | 70 mg/kg | IV/IO | not captured | standing | page 70 |
Ibuprofen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 600 mg | PO | not captured | standing | page 37 |
| Mild to moderate pain | peds | 10 mg/kg | PO | not captured | standing | page 37 |
Insulin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 10 unit | IV/IO | not captured | standing | page 142 |
| Hyperkalemia | peds | 0.1 unit/kg | IV/IO | not captured | standing | page 142 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 500 mcg | NEB | not captured | standing | pages 23, 25 |
| Asthma / bronchospasm | peds | 250 mcg | NEB | not captured | standing | pages 23, 25 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 4 mg/kg | IM | not captured | standing | page 21 |
| Mild to moderate pain | adult | 0.15 mg/kg | IV/IO | not captured | standing | page 37 |
| Mild to moderate pain | adult | 0.3 mg/kg | IM/IN | not captured | standing | page 37 |
| Procedural sedation | adult | 1 mg/kg | IM | not captured | standing | page 124 |
| Procedural sedation | adult | 50 mg | IM | not captured | standing | page 145 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 15 mg | IV | not captured | standing | page 37 |
| Mild to moderate pain | adult | 30 mg | IM | not captured | standing | page 37 |
| Mild to moderate pain | peds | 0.5 mg/kg | IV | not captured | standing | page 37 |
| Mild to moderate pain | peds | 0.5 mg/kg | IM | not captured | standing | page 37 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 61 |
| Wide-complex tachycardia | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | page 68 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2–4 g | IV/IO | not captured | standing | pages 23, 26 |
| Asthma / bronchospasm | peds | 25 mg/kg | IV/IO | not captured | standing | pages 23, 26 |
| Other | adult | 2–4 g | IV/IO | not captured | standing | page 32 |
| Seizure | adult | 2–4 g | IV/IO | not captured | standing | page 39 |
| Wide-complex tachycardia | adult | 2–4 g | IV/IO | not captured | standing | pages 61, 68 |
| Wide-complex tachycardia | peds | 2–4 g | IV/IO | not captured | standing | pages 61, 68 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 125 mg | IV/IO/IM | not captured | standing | page 15 |
| Adrenal crisis | peds | 2 mg/kg | IV/IO/IM | not captured | standing | page 15 |
| Anaphylaxis | adult | 125 mg | IV/IO/IM | not captured | standing | pages 16, 17 |
| Anaphylaxis | peds | 2 mg/kg | IV/IO/IM | not captured | standing | pages 16, 17 |
| Asthma / bronchospasm | adult | 125 mg | IV/IO/IM | not captured | standing | pages 23, 26 |
| Asthma / bronchospasm | peds | 2 mg/kg | IV/IO/IM | not captured | standing | pages 23, 26 |
Metoprolol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 2.5–5 mg | IV/IO | not captured | standing | page 56 |
| Other | adult | 5 mg | IV | not captured | standing | page 157 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 10 mg | IN | not captured | standing | page 21 |
| Agitation | adult | 5 mg | IV/IO/IM | not captured | standing | page 21 |
| Agitation | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 21 |
| Nerve agent exposure | adult | 10 mg | IN | not captured | standing | pages 29, 30 |
| Nerve agent exposure | adult | 5 mg | IV/IO/IM | not captured | standing | pages 29, 30 |
| Other | adult | 0.05 mg/kg | IV/IO | not captured | standing | page 89 |
| Other | adult | 2–6 mg | IV/IO/IM | not captured | standing | page 32 |
| Other | adult | 2–6 mg | IN | not captured | standing | page 32 |
| Other | adult | 2–6 mg | IV/IO/IM/IN | not captured | standing | page 38 |
| Other | peds | 0.05 mg/kg | IV/IO/IM/IN | not captured | standing | page 38 |
| Procedural sedation | adult | 2–10 mg | IN | not captured | standing | page 124 |
| Procedural sedation | peds | 0.05 mg/kg | IV/IO/IM/IN | not captured | standing | page 124 |
| Seizure | adult | 10 mg | IN | not captured | standing | pages 39, 40 |
| Seizure | adult | 5 mg | IV/IO/IM | not captured | standing | pages 39, 40 |
| Seizure | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | pages 39, 40 |
| Seizure | peds | 0.2 mg/kg | IN | not captured | standing | pages 39, 40 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 37 |
| Mild to moderate pain | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 37 |
| Procedural sedation | adult | 0.1 mg/kg | IV/IO/IM/SQ | not captured | standing | page 124 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.4 mg | IM/IN | not captured | standing | page 38 |
| Opioid overdose | peds | 0.1 mg/kg | IM/IN | not captured | standing | page 38 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 1 tablet | SL | not captured | standing | pages 53, 162 |
| CHF / pulmonary edema | adult | 0.4–0.8 mg | SL | not captured | standing | page 63 |
| CHF / pulmonary edema | adult | 1 inch | TOP | not captured | standing | page 63 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.1–0.5 mcg/kg | IV/IO | not captured | standing | page 16 |
| Hypotension / shock | adult | 0.1–0.5 mcg/kg | IV/IO | not captured | standing | pages 42, 44 |
| Other | adult | 0.1–0.5 mcg/kg | IV/IO | not captured | standing | page 79 |
| Sepsis | adult | 0.1–0.5 mcg/kg | IV/IO | not captured | standing | page 45 |
Olanzapine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 5–10 mg | PO/ODT | not captured | standing | pages 21, 103 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | PO/ODT | not captured | standing | page 37 |
| Nausea / vomiting | adult | 4 mg | IV/IM | not captured | standing | page 37 |
| Nausea / vomiting | peds | 2 mg | PO/ODT | not captured | standing | page 37 |
| Nausea / vomiting | peds | 2 mg | IV/IM | not captured | standing | page 37 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 1 tube | PO | not captured | standing | pages 18, 19 |
| Hypoglycemia | peds | 0.5 tube | PO | not captured | standing | pages 18, 19 |
Oxytocin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 10 mg | IM | not captured | standing | page 32 |
| Obstetric hemorrhage | adult | 20 unit | IV | not captured | standing | page 32 |
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 1–2 g | IV/IO | not captured | standing | page 29 |
Racemic Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Croup | peds | 11.25 mg | NEB | not captured | standing | page 86 |
Risperidone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2 mg | PO/ODT | not captured | standing | pages 21, 103 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 59, 60, 61, 62 |
| Cardiac arrest | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 59, 60, 61, 62 |
| Crush injury | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 78, 141 |
| Crush injury | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 78, 141 |
| Hyperkalemia | adult | 0.5–2 mEq/kg | IV | not captured | standing | page 142 |
| Hyperkalemia | peds | 0.5–2 mEq/kg | IV | not captured | standing | page 142 |
| Other | adult | 0.5–1 mEq/kg | IV/IO | not captured | standing | pages 38, 60, 61, 62 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 38, 60, 61, 62 |
Sodium Nitrite
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 10 mL | IV/IO | not captured | standing | page 38 |
| Cyanide poisoning | peds | 0.2 mL/kg | IV/IO | not captured | standing | page 38 |
Sodium Thiosulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 50 mL | IV/IO | not captured | standing | page 38 |
| Cyanide poisoning | peds | 5 mL | IV/IO | not captured | standing | page 38 |
Tetracaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 1–2 drop | not captured | not captured | standing | page 73 |
| Mild to moderate pain | peds | 1–2 drop | not captured | not captured | standing | page 73 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 2 g | IV | not captured | standing | page 32 |
| Other | adult | 2 g | IV | not captured | standing | page 110 |
| Trauma / hemorrhage | adult | 2 g | IV | not captured | standing | page 75 |
| Trauma / hemorrhage | peds | 15 mg/kg | IV | not captured | standing | page 75 |
| Traumatic arrest | adult | 2 g | IV | not captured | standing | page 83 |
| Traumatic arrest | peds | 15 mg/kg | IV | not captured | standing | page 83 |